Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients
Clinical trial NCT05019040 · COMPLETED
Trial details
- NCT number
- NCT05019040
- Sponsor
- Zhejiang Palo Alto Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-17
- Primary completion
- 2022-11-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.